Low MOQ for Vitamin K2 Mk7 (Menatetrenone) - Lipase – Puyer
Low MOQ for Vitamin K2 Mk7 (Menatetrenone) - Lipase – Puyer Detail:
Product Detail
Name:Lipase
Feature:
1.Degrade effectively the xylan which is the anti-nutritional factors in plant feed; reduce the viscosity of chyme in gastrointestinal tract.
2.Improve the secretion and the enzyme activity of endogenous enzyme, stimulate the digestion and absorption of nutritional substances, and improve the feed rate of utilization.
3.Promote the growth of beneficial bacteria in animal gut and restrain the breeding of harmful bacteria. Improve the survival rate and immunity of the animals.
4.Enhance the absorption of nitrogen and phosphorus and reduce the environment pollution.
Composition:
Assay: 10000U/G
Appearance:Powder
Packing:25kg
Shelf Life: 2 years
Storage: Store in cool and dry area
Certification:ISO,GMP,FamiQS
Product detail pictures:
Related Product Guide:
Cooperation
We emphasize development and introduce new products into the market every year for Low MOQ for Vitamin K2 Mk7 (Menatetrenone) - Lipase – Puyer, The product will supply to all over the world, such as: Thailand , Istanbul , Dominica , When It produced, it making use of the world's major method for reliable operation, a low failure price, it appropriate for Jeddah shoppers choice. Our enterprise. s situated inside the national civilized cities, the website traffic is very hassle-free, unique geographical and financial circumstances. We pursue a "people-oriented, meticulous manufacturing, brainstorm, make brilliant" company philosophy. Strict good quality management, fantastic service, affordable cost in Jeddah is our stand around the premise of competitors. If needed, welcome to make contact with us by our web page or phone consultation, we will be delighted to serve you.
By Emma
from Curacao
- 2018.06.19 10:42
The factory has advanced equipment, experienced staffs and good management level, so product quality had assurance, this cooperation is very relaxed and happy!
By Maria
from Mombasa
- 2018.12.14 15:26
